The Effects of Methylphenidate on the Classroom Behavior of Elementary School—Age Children With Cerebral Palsy: A Preliminary Observational Analysis

Abstract

High- and low-dose methylphenidate administration was evaluated prospectively for 3 elementary school—age children with cerebral palsy, cognitive impairments, and attention-deficit hyperactivity disorder (ADHD) symptoms using single-case, randomized, double-blind, placebo-controlled designs. An observational time sampling protocol was used to directly measure and quantify classroom behavior. Summary level analysis showed that (1) low-dose (0.3 mg/kg/dose) administration was associated with clinically significant (>50%) reductions in stereotyped and disruptive behavior relative to baseline and placebo conditions, (2) high-dose (0.5 mg/kg/dose) administration was associated with exacerbated amounts of stereotyped and disruptive behavior, and (3) no changes were directly observed for task-related behavior at either dose. Results are discussed with respect to previous research with methylphenidate administration and cerebral palsy, and the suggestion is made that further work using larger, randomly selected study samples with complementary measures of behavior and performance appears warranted.

Keywords

methylphenidate cerebral palsy ADHD

Get full access to this article

View all access options for this article.

References

Dormans JP , Pellegrino L. Caring for Children With Cerebral Palsy: A Team Approach. Baltimore, Md: Paul H Brookes; 1998.

Harris J. Cerebral palsy. In: Howlin P , ed. Behavior Approaches to Problems in Childhood. London, UK: MacKeith Press; 1998 : 136-151.

Eicher PS , Batshaw ML Cerebral palsy. Pediatr Clin North Am. 1993 ;40:537-551.

Palmer FB , Hoon AH Cerebral palsy. In: Parker S , Zuckerman B , eds. Behavioral and Developmental Pediatrics: A Handbook for Primary Care. Boston, Mass: Little, Brown; 1995:88-94.

Breslau N. Psychiatric disorder in children with physical disabilities. J Am Acad Child Psychol. 1985;24:87-94.

Adesman AR , Morgan AM Management of stimulant medications in children with attention-deficit/hyperactivity disorder. Pediatr Clin North Am. 1999;46:945-963.

Handen BL , Breaux AM , Gosling A. , et al. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorders. Pediatrics . 1990;86:922-930.

MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1073-1086.

Sabbadini M. , Bonanni R. , Carlesimo GA , Caltagirone C. Neuropsychological assessment of patients with severe neuromotor and verbal disabilities. J Intellect Disabil. 2001;45:169-179.

10.

Mayes SD , Crites DL , Bixler EO , et al. Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status. Develop Med Child Neurol. 1994;36:1099-1107.

11.

Tervo RC , Estrem TL , Bryson-Brockmann W. , Symons FJ Single-case experimental designs: applications in developmental-behavioral pediatrics. J Dev Behav Pediatr. 2003;24:1-11.

12.

Tervo R. Part II: decisions in the management of a child with developmental disability and hyperactive-impulsive behavior using “n of 1” trials in the clinical setting. Child Adolesc Psychopharm News. 2000;5:6-7.

13.

Varley CK , Trupin EW Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder: a preliminary study. Am J Ment Defic. 1982; 86:560-566.

14.

Handen BL , Janosky J. , McAuliffe S. Long-term follow-up of children with mental retardation/borderline intellectual functioning and ADHD. J Abnorm Child Psychol. 1997;25:287-295.

15.

Handen BL , Feldman HM , Lurier A. , Murray PJ Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. J Am Acad Child Adolesc Psychiatry. 1999;38:805-812.

16.

Johnson CR , Handen BL , Lubetsky MJ , Sacco KA Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation. Behav Modif . 1994;18:470-487.

17.

Gross-Tsur V. , Shalev RS , Badihi N. , Manor O. Efficacy of methylphenidate in patients with cerebral palsy and attention-deficit hyperactivity disorder (ADHD). J Child Neurol. 2002;17: 863-866.

18.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.

19.

Barkley R. , Fischer M. , Newby RF , et al. Development of a multimethod clinical protocol for the assessing stimulant drug response in children with attention deficit disorder. J Clin Child Psychol. 1988;17:14-24.

20.

Blum NJ , Mauk JE , McComas JJ , Mace FC Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation. J Appl Behav Anal. 1996;29:305-319.

21.

Boogerd W. , Beijnen JH Methylphenidate for cerebral palsy with choreoathetosis. Ann Intern Med. 2000;132:510.

22.

Symons FJ , Thompson A. , Rodriguez MC Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis. Ment Retard Dev Disabil Res Rev. 2004;10:193-200.

23.

Breese GR , Criswell HE , Duncan GE , et al. Model for reduced brain dopamine in Lesch-Nyhan syndrome and the mentally retarded: neurobiology of neonatal-6-hydroxydopamine lesioned rats. Ment Retard Dev Disabil Res Rev. 1995 ;1:111-119.

24.

Lewis MH , Bodfish JW , Powell SB , Golden RN Clomipramine treatment for stereotypy and related repetitive movement disorders in mental retardation: a double-blind comparison with placebo. Am J Ment Retard. 1996;100:299-312.

25.

Bodfish JW , Powell SB , Golden RN , Lewis MH Blink rate as an index of dopamine function in adults with mental retardation and repetitive behavior disorders. Am J Ment Retard. 1995; 99:335-344.